![Iris Löw-Friedrich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Iris Löw-Friedrich
Director/Board Member at
FINANCIÈRE DE TUBIZE S.A.
Net worth: 215 653 $ as of 2026-05-30
Profile
Dr. Iris Löw-Friedrich is a Vice Chairman-Supervisory Board at Evotec SE, a Chief Medical Officer & Executive Vice President at UCB SA and a Professor at Johann Wolfgang Goethe-Universität Frankfurt am Main. She is on the Board of Directors at Fresenius SE & Co. KGaA and Evotec SE. Dr. Löw-Friedrich was previously employed as a Chairman by Transcelerate Biopharma, Inc., a Member-Supervisory Board by Heidelberg Pharma AG, a Director-Research & Development by UCB Pharma GmbH, a Vice President-Global Projects by BASF Pharma, a Vice President-Global Projects by BASF AG, a Vice President-Clinical Development by Hoechst AG, a Head-Global Clinical Management & VP by Aventis Pharma AG, and a Vice President-Clinical Development by Hoechst Marion Roussel, Inc. She received her doctorate degree from Johann Wolfgang Goethe-Universität Frankfurt am Main.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EVOTEC SE 0.02% | 2025-12-30 | 35,000 ( 0.02% ) | 215 653 $ | 2026-05-30 |
| 2026-01-29 | 0 ( -.--% ) | - $ | 2026-05-30 |
Iris Löw-Friedrich active positions
| Companies | Position | Start |
|---|---|---|
| FRESENIUS SE & CO. KGAA | Director/Board Member | 2016-05-12 |
| SWEDISH ORPHAN BIOVITRUM AB | Director/Board Member | 2025-05-07 |
| SATELLOS BIOSCIENCE INC. | Director/Board Member | 2025-06-17 |
| FINANCIÈRE DE TUBIZE S.A. | Director/Board Member | 2025-09-23 |
| BIONTECH SE | Director/Board Member | 2026-05-14 |
Celosia Therapeutics Pty Ltd.
 Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Chairman | - |
PhRMA Foundation
 PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Director/Board Member | 2019-03-31 |
Johann Wolfgang Goethe-Universität Frankfurt am Main
 Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 1999-12-31 |
Former positions of Iris Löw-Friedrich
| Companies | Position | End |
|---|---|---|
| EVOTEC SE | Chairman | 2026-06-10 |
| ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Iris Löw-Friedrich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
20
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 20 |
|---|---|
Fresenius SE & Co. KGaA
 Fresenius SE & Co. KGaA Hospital/Nursing ManagementHealth Services Develops and manufactures generic drugs, biopharmaceuticals, infusion & nutrition therapies and medical devices | Health Services |
Hoechst AG
 Hoechst AG Chemicals: Major DiversifiedProcess Industries Produces specialty chemicals and pharmaceutical products | Process Industries |
BASF SE
 BASF SE Chemicals: SpecialtyProcess Industries Manufactures plastic materials, precursors, chemicals for batteries, automotive OEM coatings, petrochemicals, intermediates, agrochemicals, industrial, nutrition & care additives | Process Industries |
UCB Pharma GmbH
 UCB Pharma GmbH Pharmaceuticals: MajorHealth Technology Develops and markets drugs | Health Technology |
Zogenix, Inc.
 Zogenix, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets medicines | Health Technology |
UCB SA
 UCB SA Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceutical products | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Heidelberg Pharma AG
 Heidelberg Pharma AG Pharmaceuticals: MajorHealth Technology Develops cancer therapies | Health Technology |
Financière de Tubize SA
 Financière de Tubize SA Financial ConglomeratesFinance Operates as an investment holding company which invests in the chemical, pharmaceutical and film sectors | Finance |
Johann Wolfgang Goethe-Universität Frankfurt am Main
Johann Wolfgang Goethe-Universität Frankfurt am Main Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aventis Pharma AG | |
Hoechst Marion Roussel, Inc.
 Hoechst Marion Roussel, Inc. Pharmaceuticals: GenericHealth Technology Develops, manufactures and sells generic pharmaceutical products | Health Technology |
BioNTech SE
 BioNTech SE BiotechnologyHealth Technology Develops immunotherapies and mRNA-based vaccines to treat cancer & infectious diseases | Health Technology |
Swedish Orphan Biovitrum AB
 Swedish Orphan Biovitrum AB Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceuticals and orphan drugs in the areas of hematology, immunology and specialty care | Health Technology |
BASF Pharma | |
PhRMA Foundation
PhRMA Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development of drugs | Commercial Services |
Transcelerate Biopharma, Inc.
 Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Provides biopharmaceutical research services | Health Technology |
Satellos Bioscience, Inc.
 Satellos Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company, which is focused on the identification, development and commercialization of drug candidates | Health Technology |
Frankfurt University Medical School
 Frankfurt University Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Celosia Therapeutics Pty Ltd.
Celosia Therapeutics Pty Ltd. BiotechnologyHealth Technology Operates as a biotechnology company which uses gene therapy to treat neurodegenerative diseases | Health Technology |
- Stock Market
- Insiders
- Iris Löw-Friedrich
